Benjamin Bay, Raman Sharma, Anastasios Roumeliotis, David Power, Samantha Sartori, Jonathan Murphy, Birgit Vogel, Kenneth F Smith, Angelo Oliva, Amit Hooda, Joseph Sweeny, George Dangas, Annapoorna Kini, Prakash Krishnan, Samin K Sharma, Roxana Mehran
Percutaneous coronary intervention (PCI) has demonstrated its safety and efficacy in treating left main coronary artery disease (LM-CAD) in select patients. Polyvascular disease (PolyVD) is associated with adverse events in all-comers with CAD. However, there is little data examining the interplay between PolyVD and LM-PCI, which we sought to investigate in a retrospective single-center study. We included patients undergoing unprotected LM-PCI at a tertiary center from 2012-2019. The patient population was stratified based on the presence or absence of PolyVD (i...
April 30, 2024: American Journal of Cardiology